Tao, Y., Li, H., Huang, R., Mo, D., Zeng, T., Fang, M., & Li, M. (2018). Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies. Cellular physiology and biochemistry, 46(4), 1716-1726. https://doi.org/10.1159/000489586
Chicago Style (17th ed.) CitationTao, Yifeng, Hui Li, Rongyong Huang, Dan Mo, Tian Zeng, Min Fang, and Meiqin Li. "Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies." Cellular Physiology and Biochemistry 46, no. 4 (2018): 1716-1726. https://doi.org/10.1159/000489586.
MLA (9th ed.) CitationTao, Yifeng, et al. "Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies." Cellular Physiology and Biochemistry, vol. 46, no. 4, 2018, pp. 1716-1726, https://doi.org/10.1159/000489586.